WallStSmart

Quipt Home Medical Corp (QIPT)vsTrip.com Group Ltd ADR (TCOM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Trip.com Group Ltd ADR generates 23453% more annual revenue ($62.41B vs $264.97M). TCOM leads profitability with a 53.3% profit margin vs -4.0%. TCOM earns a higher WallStSmart Score of 81/100 (A-).

QIPT

Hold

40

out of 100

Grade: D

Growth: 7.3Profit: 2.5Value: 5.0Quality: 5.0

TCOM

Exceptional Buy

81

out of 100

Grade: A-

Growth: 9.3Profit: 8.0Value: 10.0Quality: 6.5
Piotroski: 4/9Altman Z: 1.73
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for QIPT.

TCOMUndervalued (+82.1%)

Margin of Safety

+82.1%

Fair Value

$323.86

Current Price

$51.34

$272.52 discount

UndervaluedFair: $323.86Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

QIPT2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
32.0%10/10

Revenue surging 32.0% year-over-year

Price/BookValuation
1.6x8/10

Reasonable price relative to book value

TCOM6 strengths · Avg: 9.7/10
P/E RatioValuation
7.4x10/10

Attractively priced relative to earnings

Price/BookValuation
1.4x10/10

Reasonable price relative to book value

Profit MarginProfitability
53.3%10/10

Keeps 53 of every $100 in revenue as profit

EPS GrowthGrowth
97.8%10/10

Earnings expanding 97.8% YoY

Return on EquityProfitability
21.1%9/10

Every $100 of equity generates 21 in profit

Debt/EquityHealth
0.199/10

Conservative balance sheet, low leverage

Areas to Watch

QIPT4 concerns · Avg: 2.5/10
Market CapQuality
$162.30M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
1.5%3/10

Operating margin of 1.5%

Return on EquityProfitability
-9.3%2/10

ROE of -9.3% — below average capital efficiency

EPS GrowthGrowth
-97.7%2/10

Earnings declined 97.7%

TCOM2 concerns · Avg: 4.0/10
PEG RatioValuation
1.914/10

Expensive relative to growth rate

Altman Z-ScoreHealth
1.734/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : QIPT

The strongest argument for QIPT centers on Revenue Growth, Price/Book. Revenue growth of 32.0% demonstrates continued momentum.

Bull Case : TCOM

The strongest argument for TCOM centers on P/E Ratio, Price/Book, Profit Margin. Profitability is solid with margins at 53.3% and operating margin at 16.5%. Revenue growth of 20.8% demonstrates continued momentum.

Bear Case : QIPT

The primary concerns for QIPT are Market Cap, Operating Margin, Return on Equity.

Bear Case : TCOM

The primary concerns for TCOM are PEG Ratio, Altman Z-Score.

Key Dynamics to Monitor

QIPT profiles as a hypergrowth stock while TCOM is a growth play — different risk/reward profiles.

QIPT carries more volatility with a beta of 0.49 — expect wider price swings.

QIPT is growing revenue faster at 32.0% — sustainability is the question.

Monitor MEDICAL DISTRIBUTION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

TCOM scores higher overall (81/100 vs 40/100), backed by strong 53.3% margins and 20.8% revenue growth. Both earn "Exceptional Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Quipt Home Medical Corp

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Quipt Home Medical Corp. The company is headquartered in Wilder, Kentucky.

Trip.com Group Ltd ADR

CONSUMER CYCLICAL · TRAVEL SERVICES · China

Trip.com Group Limited is a travel service provider for accommodation booking, transportation ticketing, destination and package tours, corporate travel management and other travel-related services in China and internationally. The company is headquartered in Shanghai, the People's Republic of China.

Visit Website →

Want to dig deeper into these stocks?